A detailed history of Tower Research Capital LLC (Trc) transactions in Wave Life Sciences Ltd. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 6,579 shares of WVE stock, worth $88,684. This represents 0.0% of its overall portfolio holdings.

Number of Shares
6,579
Previous 7,748 15.09%
Holding current value
$88,684
Previous $38,000 39.47%
% of portfolio
0.0%
Previous 0.0%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$5.12 - $9.01 $5,985 - $10,532
-1,169 Reduced 15.09%
6,579 $53,000
Q2 2024

Aug 13, 2024

BUY
$4.38 - $6.48 $31,623 - $46,785
7,220 Added 1367.42%
7,748 $38,000
Q1 2024

May 15, 2024

SELL
$3.54 - $6.84 $38,256 - $73,919
-10,807 Reduced 95.34%
528 $3,000
Q4 2023

Feb 13, 2024

BUY
$4.16 - $6.87 $38,754 - $64,000
9,316 Added 461.42%
11,335 $57,000
Q3 2023

Nov 14, 2023

BUY
$3.56 - $5.75 $1,178 - $1,903
331 Added 19.61%
2,019 $11,000
Q2 2023

Aug 14, 2023

SELL
$3.51 - $4.69 $15,766 - $21,067
-4,492 Reduced 72.69%
1,688 $6,000
Q1 2023

May 09, 2023

BUY
$3.58 - $6.3 $279 - $491
78 Added 1.28%
6,180 $27,000
Q4 2022

Feb 10, 2023

SELL
$3.18 - $7.0 $9,905 - $21,805
-3,115 Reduced 33.8%
6,102 $43,000
Q3 2022

Nov 10, 2022

BUY
$2.37 - $4.28 $15,713 - $28,376
6,630 Added 256.28%
9,217 $34,000
Q2 2022

Aug 15, 2022

SELL
$1.23 - $3.25 $2,736 - $7,231
-2,225 Reduced 46.24%
2,587 $8,000
Q1 2022

May 12, 2022

SELL
$2.0 - $3.28 $8,882 - $14,566
-4,441 Reduced 48.0%
4,812 $10,000
Q4 2021

Feb 14, 2022

SELL
$3.14 - $5.15 $26,429 - $43,347
-8,417 Reduced 47.63%
9,253 $29,000
Q3 2021

Nov 15, 2021

BUY
$4.89 - $7.12 $25,677 - $37,387
5,251 Added 42.28%
17,670 $86,000
Q2 2021

Aug 16, 2021

BUY
$5.65 - $7.47 $7,644 - $10,106
1,353 Added 12.23%
12,419 $82,000
Q1 2021

May 17, 2021

BUY
$5.61 - $12.01 $38,063 - $81,487
6,785 Added 158.49%
11,066 $62,000
Q4 2020

Feb 16, 2021

SELL
$6.99 - $9.26 $78,364 - $103,813
-11,211 Reduced 72.37%
4,281 $34,000
Q3 2020

Nov 16, 2020

BUY
$8.49 - $19.54 $97,015 - $223,283
11,427 Added 281.11%
15,492 $132,000
Q2 2020

Aug 13, 2020

BUY
$7.44 - $11.29 $30,243 - $45,893
4,065 New
4,065 $42,000
Q1 2020

May 15, 2020

SELL
$6.94 - $14.22 $3,393 - $6,953
-489 Closed
0 $0
Q4 2019

Feb 07, 2020

BUY
$7.99 - $37.6 $3,907 - $18,386
489 New
489 $4,000
Q1 2019

May 14, 2019

SELL
$32.69 - $47.91 $23,242 - $34,064
-711 Closed
0 $0
Q4 2018

Feb 14, 2019

BUY
$37.1 - $50.11 $11,760 - $15,884
317 Added 80.46%
711 $30,000
Q3 2018

Nov 13, 2018

BUY
$36.35 - $55.2 $14,321 - $21,748
394 New
394 $20,000
Q1 2018

May 15, 2018

SELL
$32.45 - $54.7 $22,650 - $38,180
-698 Closed
0 $0
Q4 2017

Feb 09, 2018

SELL
$21.8 - $39.35 $53,279 - $96,171
-2,444 Reduced 77.78%
698 $24,000
Q3 2017

Nov 14, 2017

BUY
$16.4 - $25.05 $51,528 - $78,707
3,142
3,142 $68,000

Others Institutions Holding WVE

About Wave Life Sciences Ltd.


  • Ticker WVE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 86,820,096
  • Market Cap $1.17B
  • Description
  • Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It is developing oligonucleotides target ribonucleic acid to reduce the expression of disease-promoting proteins or restore the production of functional pr...
More about WVE
Track This Portfolio

Track Tower Research Capital LLC (Trc) Portfolio

Follow Tower Research Capital LLC (Trc) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.